browse Browse

pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
c3531ea3-ab5c-4bdc-afe8-8deb33c33c9a
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-20 17:21:06
Income (reported)
$80,000
Expenses (reported)
Filing document
Open on lda.senate.gov
Registrant (lobbying firm)

BGR GOVERNMENT AFFAIRS

Lobbying firm

Contact
CHELSEA MINCHEFF
Phone
+1 202-661-6385
Address
zip:20005, city:Washington, state:DC, street:601 13th Street, NW 11th Floor South
Client

VAXCYTE, INC.

Clinical-stage vaccine company

State
CA
Country
US
Effective date
2024-12-05
Issues lobbied + lobbyists (1)

HCR — Health Issues

Provide strategic counsel and advocate on issues related to vaccine development

Lobbyists:
  • ms REMY LEIGH BRIM MASON — covered position: Senior FDA Policy Advisor to Senate HELP Committee Ranking Member Patty Murray; Senior Health Policy Advisor Sen. Elizabeth Warren; Intern to Rep. Allyson Schwartz
  • BRENT ALAN DEL MONTE — covered position: Leg. Dir. Rep. Bliley; Sen. Counsel House Energy & Commerce Committee
  • JOHN STONE — covered position: Counsel, House E&C Cmte, Oversight Subcommittee; Senior Counsel, House E&C Cmte, Health Subcommittee; Intern, House E&C
  • CHRIS KELLY — covered position: Health Policy Dir., Leg. Asst., Leg. Corr., Front Office Coordinator, Staff Asst. Sen. Blackburn
  • ROBB WALTON — covered position: Senior Health Policy Advisor and Counsel Sen Cassidy; Advisor Rep. Cassidy; Research Asst., Staff Asst., Intern on Senate HELP, Ranking Member, Sen. Enzi; Intern to Rep. Nunes

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.